Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 4097

The New York Times reports Google founders Larry Page and Sergey Brin have discussed its response to ChatGPT, with plans to launch over 20 AI products this year, including a demo of its own search chatbot.

The recent launch of OpenAI’s AI chatbot ChatGPT has raised alarms within Google, according to reports from The.

As recently as December, we’d heard Google execs were worried that despite investing heavily in AI technology, moving too fast to roll it out could harm the company’s reputation.

Expect to see a Google search AI chatbot demo this year.

Continue reading “Google is freaking out about ChatGPT” | >

The wetware in a casket of bone that we each carry on our shoulders is 1 million times more efficient than the AI models run by services like ChatGPT, Stable Diffusion, or DALL-E.

In this TechFirst with John Koetsier we chat for a second time with Gordon Wilson, CEO of Rain AI, which is building a neuromorphic artificial brain simulating the structure of our biological brains, and aiming at 10,000 to 100,000 greater energy efficiency than current AI architectures.

We also discuss “mortal computation” and a radical co-design of the hardware and software for AI systems, which could lead to much more efficient (and more effective) smart tools, machines, and companions.

Links:

Continue reading “Our brains are 1 million times more efficient than ChatGPT: chatting with Gordon Wilson of Rain AI” | >

Summary: Researchers have developed a new family of nano-scale capsules capable of carrying CRISPR gene editing tools to different organs of the body before harmlessly dissolving. The capsules were able to enter the brains of mice and successfully edit a gene associated with Alzheimer’s disease.

Source: University of Wisconsin-Madison.

Gene therapies have the potential to treat neurological disorders like Alzheimer’s and Parkinson’s diseases, but they face a common barrier — the blood-brain barrier.

Read more | >

Dual-action cell therapy engineered to eliminate established tumors and train the immune system to eradicate primary tumor and prevent cancer’s recurrence. Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring. The team tested their dual-action, cancer-killing vaccine in an advanced mouse model of the deadly brain cancer glioblastoma, with promising results. Findings are published in Science Translational Medicine.

Read more | >

Jan. 20 (UPI) — Two astronauts embarked on the first spacewalk of 2023 on Friday as they work toward upgrading the International Space Station’s power generation system.

NASA astronaut Nicole Mann teamed up with Koichi Wakata of the Japan Aerospace Exploration Agency for the morning spacewalk, expected to last about 6 1/2 hours. They will install a modification kit at the far end of the ISS, allowing for the future installation of the roll-out solar array.

The spacewalk was scheduled to start at 8:15 a.m., EST, but NASA officials said the operation was ahead of schedule with both astronauts setting their spacesuits to battery power about a minute earlier, marking the official start of the mission.

Read more | >